• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

TherOx Inc

Zoll Medical wins CE Mark for oxygen therapy system

May 4, 2020 By Sean Whooley

Zoll Medical announced today that it received CE Mark approval in Europe for its TherOx SuperSaturated Oxygen (SSO2) therapy system. SSO2 therapy offers interventional cardiologists a treatment beyond percutaneous coronary intervention (PCI) that significantly reduces muscle damage in heart attack patients. Chelmsford, Mass.-based Zoll’s therapy system delivers hyperbaric levels of oxygen directly to damaged heart […]

Filed Under: Cardiovascular, Regulatory/Compliance, Structural Heart Tagged With: CE Mark, TherOx Inc, Zoll Medical

Zoll Medical wins FDA nod for second-gen TherOx system

March 30, 2020 By Sean Whooley

Zoll Medical Corp. announced today that it received FDA approval for its second-generation TherOx system for SuperSaturated Oxygen (SSO2) therapy in heart attack patients. The Chelmsford, Mass.–based company’s TherOx system is designed to deliver the SSO2 therapy that has been shown in clinical trials to reduce infarct size (heart muscle damage) in “widowmaker” heart attack […]

Filed Under: Cardiovascular, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: TherOx Inc, Zoll Medical

Medicare might cover more cutting-edge medtech and pay more for it, too

July 30, 2019 By Nancy Crotti

The Centers for Medicare and Medicaid Services (CMS) said today it wants to give Medicare patients better access to cutting-edge medical devices, and that it’s willing to pay more for them beginning in fiscal year 2020. In its proposed rule, CMS said it might pay more for “certain transformative new devices” for inpatients through a […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Medicare, News Well, Regulatory/Compliance Tagged With: Boston Scientific, Centers for Medicare and Medicaid Services (CMS), CivaTech Oncology Inc., Claret Medical Inc., FDA, GT Medical Technologies, IsoRay, Johnson and Johnson, Procept BioRobotics, Respicardia, TherOx Inc, Zoll Medical

Zoll acquires TherOx

June 18, 2019 By Sarah Faulkner

Zoll Medical said today that it acquired TherOx and its acute myocardial infarction treatment. TherOx’s SuperSaturated Oxygen Therapy system delivers a 60-minute infusion of the patient’s super-oxygenated blood to a targeted ischemic area of the heart via a small catheter. The treatment is designed to improve microvascular flow and reduce infarct size following primary coronary […]

Filed Under: Business/Financial News, Cardiovascular, Catheters, Featured, Mergers & Acquisitions, Vascular Tagged With: TherOx Inc, Zoll Medical

TherOx wins FDA approval for SuperSaturated Oxygen therapy

April 4, 2019 By Brad Perriello

TherOx said today that it won pre-market approval from the FDA for its SuperSaturated Oxygen Therapy system for acute myocardial infarction. Irvine, Calif.-based TherOx touted the PMA as the first heart attack treatment approved to reduce infarct size since the federal safety watchdog OK’d percutaneous coronary interventions. Indicated for patients suffering from left anterior descending […]

Filed Under: Cardiovascular, Featured, Regulatory/Compliance, Wall Street Beat Tagged With: TherOx Inc

Zoll Medical leads debt round for TherOx

May 7, 2018 By Fink Densford

TherOx said today it completed a new round of debt financing led by Asahi Kasei (TYO:3407) subsidiary Zoll Medical for an undisclosed amount. Funds from the deal will be used to support the US market introduction and commercialization of the Irvine, Calif.-based company’s SuperSaturated Oxygen Therapy system designed to treat patients with acute myocardial infarction once the system […]

Filed Under: Business/Financial News Tagged With: Asahi Kasei Corp., TherOx Inc, Zoll Medical

Zimmer Biomet prez, CEO Dvorak unexpectedly resigns | Personnel Moves, July 12, 2017

July 12, 2017 By Fink Densford

Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search […]

Filed Under: Business/Financial News Tagged With: Abiomed, Accuray Inc., Amendia, Boston Scientific, C.R. Bard, Cochlear Ltd., conformis, GE Healthcare, InVivo Corp., IsoRay, Johnson and Johnson, Lidco, Lumicell, Neurometrix, Philips, portal instruments, RenalGuard Solutions, Sanofi-Aventis, Spinal Elements, stjudemedical, Stryker, TherOx Inc, Zimmer Biomet

Bayer taps strategy head Baumann for CEO | Personnel Moves

February 24, 2016 By Brad Perriello

Bayer (ETR:BAYN) named strategy chief Werner Baumann to replace Marijn Dekkers as CEO today, prompting some industry watchers to speculate that there’s more deal-making ahead for the German firm’s non-pharma markets. Baumann, who’s slated to succeed Dekkers May 1, joined Bayer in 1988 and made a name for himself with the successful integration of rival drugmaker […]

Filed Under: Business/Financial News Tagged With: Apollo Medical, Battelle, Bayer, Bruker Corp., Calmare Therapeutics Inc, Dana-Farber Cancer Institute, DiaMedica, intersectent, Personnel Moves, Positron Corp., TherOx Inc

TherOx wins FDA IDE nod for Supersaturated Oxygen therapy

November 5, 2015 By Fink Densford

Irvine, Calif.-based oxygenation therapy company TherOx said today it won FDA investigational device exemption approval to test its 2nd-generation Supersaturated Oxygen therapy system for treating acute myocardial infarction. The company’s SSO2 therapy is designed to reduce infarct size by increasing oxygen delivery to heart muscle immediately after the coronary artery has been opened through a […]

Filed Under: Blood Management, Cardiovascular, Food & Drug Administration (FDA) Tagged With: TherOx Inc

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS